A new breast cancer vaccine has completed phase 1 clinical trials, showing promising results. Developed by Anixa Biosciences in collaboration with Cleveland Clinic, the vaccine aims to prevent breast cancer by targeting a specific protein. The trial involved 35 high-risk women, with over 75% developing a strong immune response. Phase 2 trials are set to begin in 2026, marking a significant step towards potentially preventing breast cancer. #breastcancer #cancervaccine #medicalresearch #itwebvideos #clinicaltrials #medicalbreakthrough #cancerprevention #womenshealth #healthinnovation
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
